Antibiotics for the newborn

References

• Clark R H, Bloom B T, Spitzer A R, Gerstmann D R. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006; 117: 1979–1987
   PubMed Web of Science ®Google Scholar
• Palazzi D R, Klein J O, Baker C J. Bacterial sepsis and meningitis. Infectious Diseases of the Fetus and Newborn Infant6th ed, J S Remington, J O Klein. Elsevier Saunders Company, Philadelphia 2006; 248–295
   Google Scholar
• Chirico G. Development of the immune system in neonates. J Arab Neonatal Forum 2005; 2: 5–11
   Google Scholar
• Fanos V, Cuzzolin L, Atzei A, Testa M. Antibiotics and antifungals in neonatal intensive care units: a review. J Chemother 2007; 19: 5–20
   PubMed Web of Science ®Google Scholar
• de Hoog M, Mouton J W, van den Anker J N. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 2005; 10: 185–194
   PubMed Web of Science ®Google Scholar
• J S Remington, Klein, J O. Infectious Diseases of the Fetus and Newborn Infant6th ed. Philadelphia, W.B. Saunders Company. 2006
   Google Scholar
• Rao S C, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2006, 1: CD005091
   Google Scholar
• Nestaas E, Bangstad H J, Sandvik L, Wathne K O. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2005; 90: F294–F300
   PubMed Web of Science ®Google Scholar
• Clark R H, Bloom B T, Spitzer A R, Gerstmann D R. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117: 67–74
   PubMed Web of Science ®Google Scholar
• Cotten C M, McDonald S, Stoll B, Goldberg R N, Poole K, Benjamin D K, Jr, National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006; 118: 717–722
   PubMed Web of Science ®Google Scholar
• Benjamin D K, Jr, Stoll B J, Fanaroff A A, McDonald S A, Oh W, Higgins R D, Duara S, Poole K, Laptook A, Goldberg R, National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006; 117: 84–92
   PubMed Web of Science ®Google Scholar
• Cotten C M, Taylor S, Stoll B, Goldberg R N, Hansen N I, Sánchez P J, Ambalavanan N, Benjamin D K, Jr, NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123: 58–66
   PubMed Web of Science ®Google Scholar
• Sehgal R, Gaind R, Chellani H, Agarwal P. Extended-spectrum β lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. Ann Trop Paediatr 2007; 27: 45–54
   PubMed Web of Science ®Google Scholar
• Kumar S, Kohlhoff S, Valencia G, Hammerschlag M R, Sharma R. Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate. Int J Antimicrob Agents 2007; 29: 740–741
   PubMed Web of Science ®Google Scholar
• Hufnagel M, Liese C, Loescher C, Kunze M, Proempeler H, Berner R, Krueger M. Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns. BMC Infect Dis 2007; 7: 107
   PubMed Web of Science ®Google Scholar
• Plan O, Cambonie G, Barbotte E, Meyer P, Devine C, Milesi C, Pidoux O, Badr M, Picaud J C. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented gram-positive infections: a new dosage schedule. Arch Dis Child Fetal Neonatal Ed 2008; 93: F418–F421
   PubMed Web of Science ®Google Scholar
• Rubin L G, Sánchez P J, Siegel J, Levine G, Saiman L, Jarvis W R, Pediatric Prevention Network. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002; 110: e42
   PubMed Web of Science ®Google Scholar
• Scheetz M H, Knechtel S A, Malczynski M, Postelnick M J, Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008; 52: 2256–2259
   PubMed Web of Science ®Google Scholar
• Ng P C. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants. Neonatology 2009; 95: 97–104
   PubMed Web of Science ®Google Scholar
• Aghai Z H, Kode A, Saslow J G, Nakhla T, Farhath S, Stahl G E, Eydelman R, Strande L, Leone P, Rahman I. Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res 2007; 62: 483–488
   PubMed Web of Science ®Google Scholar
• Ballard H O, Anstead M I, Shook L A. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Respir Res 2007; 8: 41
   PubMed Web of Science ®Google Scholar
• Isaacs D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2006; 91: F72–F74
   Web of Science ®Google Scholar
• Alm B, Erdes L, Möllborg P, Pettersson R, Norvenius S G, Aberg N, Wennergren G. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008; 121: 697–702
   PubMed Web of Science ®Google Scholar